Publication | Closed Access

Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donors

Cell TherapyGraft-versus-host DiseaseTransplantationAutoimmune DiseaseCd56+ CellsImmunologyHematologyPathologyAutoimmunityGraft SurvivalBlood TransplantationImmunotherapyMedicineCell TransplantationGraft RejectionHla-identical Sibling Donors